MENU
+Compare
SBFM
Stock ticker: NASDAQ
AS OF
Apr 1, 04:40 PM (EDT)
Price
$2.10
Change
+$0.19 (+9.95%)
Capitalization
6.02M

SBFM Sunshine Biopharma Inc Forecast, Technical & Fundamental Analysis

Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals... Show more

SBFM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for SBFM with price predictions
Mar 31, 2025

SBFM's RSI Indicator ascending out of oversold territory

The RSI Indicator for SBFM moved out of oversold territory on March 17, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 44 similar instances when the indicator left oversold territory. In of the 44 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Moving Average Convergence Divergence (MACD) for SBFM just turned positive on March 20, 2025. Looking at past instances where SBFM's MACD turned positive, the stock continued to rise in of 39 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SBFM advanced for three days, in of 183 cases, the price rose further within the following month. The odds of a continued upward trend are .

SBFM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 31, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SBFM as a result. In of 94 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SBFM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SBFM entered a downward trend on March 24, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.482) is normal, around the industry mean (60.617). P/E Ratio (0.877) is within average values for comparable stocks, (90.174). SBFM's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.987). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (0.125) is also within normal values, averaging (20.094).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SBFM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SBFM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
SBFM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SBFM is expected to report earnings to fall 98.40% to -7 cents per share on May 08

Sunshine Biopharma Inc SBFM Stock Earnings Reports
Q1'24
Est.
$-0.08
Q4'23
Missed
by $4.97
Q3'23
Beat
by $0.02
Q2'23
Beat
by $0.06
The last earnings report on March 28 showed earnings per share of -500 cents, missing the estimate of -2 cents. With 10.95K shares outstanding, the current market capitalization sits at 6.02M.
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
6500 Trans-Canada Highway
Phone
+1 514 426-6161
Employees
83
Web
https://www.sunshinebiopharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMH37.810.23
+0.61%
American Homes 4 Rent
TZOO13.630.01
+0.07%
Travelzoo
ALG178.21-2.63
-1.45%
Alamo Group
EVER26.19-0.69
-2.57%
EverQuote
VERB4.67-0.25
-5.08%
Verb Technology Company Inc

SBFM and Stocks

Correlation & Price change

A.I.dvisor tells us that SBFM and TXMD have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SBFM and TXMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SBFM
1D Price
Change %
SBFM100%
-4.50%
TXMD - SBFM
22%
Poorly correlated
-5.80%
EVOK - SBFM
22%
Poorly correlated
-1.43%
SUPN - SBFM
22%
Poorly correlated
+1.42%
SIGA - SBFM
21%
Poorly correlated
-1.26%
RDHL - SBFM
21%
Poorly correlated
-4.66%
More